In summary, this study explored the hypothesis that administration of resveratrol in the PVN would attenuate high blood pressure via the SIRT1/NF-κB pathway, by regulating ROS and neurotransmitters during hypertension. This evidence concerns the gene SIRT1 and hypertensive disorder.